Cargando…
Developmental and reproductive safety evaluation of AV7909 anthrax vaccine candidate in rats
The AV7909 vaccine, consists of the Anthrax Vaccine Adsorbed (AVA) bulk drug substance and the immunostimulatory Toll‐like receptor 9 agonist oligodeoxynucleotide adjuvant CPG 7909. The purpose of this research was to evaluate the potential maternal, reproductive, and developmental toxicity of AV790...
Autores principales: | Mylchreest, Eve, Smiley, M. Autumn, Ballin, Jeff D., Blauth, Bruna, Shearer, Jeffry, Reece, Joshua, Ionin, Boris, Savransky, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821328/ https://www.ncbi.nlm.nih.gov/pubmed/33067910 http://dx.doi.org/10.1002/bdr2.1815 |
Ejemplares similares
-
Current Status and Trends in Prophylaxis and Management of Anthrax Disease
por: Savransky, Vladimir, et al.
Publicado: (2020) -
368. A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Immunogenicity and Safety of AV7909 for Post-exposure Prophylaxis of Anthrax in Healthy Adults
por: Akintunde, Gideon, et al.
Publicado: (2023) -
1159. A Phase 2 Drug-Vaccine Interaction Study of AV7909 and Ciprofloxacin or Doxycycline on Antibiotic Pharmacokinetics
por: Akintunde, Gideon, et al.
Publicado: (2023) -
Radiosensitization by CpG ODN7909 in an epidermoid laryngeal
carcinoma Hep-2 cell line
por: Wang, Shu, et al.
Publicado: (2017) -
AV monografías = AV monographs.
Publicado: (1995)